Back to Search
Start Over
Contrast-enhanced ultrasonography of hepatocellular carcinoma after chemoembolisation using drug-eluting beads: a pilot study focused on sustained tumor necrosis
- Source :
- Cardiovascular and interventional radiology. 33(5)
- Publication Year :
- 2009
-
Abstract
- The purpose of this study was to assess the use of contrast-enhanced ultrasonography (CEUS) and the sustained antitumor effect of drug-eluting beads used for transarterial chemoembolisation (TACE) of unresectable hepatocellular carcinoma (HCC). Ten patients with solitary, unresectable HCC underwent CEUS before, 2 days after, and 35 to 40 days after TACE using a standard dose (4 ml) of drug-eluting beads (DC Beads; Biocompatibles, Surrey, UK) preloaded with doxorubicin (25 mg doxorubicin/ml hydrated beads). For CEUS, a second-generation contrast agent (SonoVue, Bracco, Milan, Italy) and a low mechanical-index technique were used. A part of the tumor was characterized as necrotic if it showed complete lack of enhancement. The percentage of necrosis was calculated at the sonographic section that depicted the largest diameter of the tumor. Differences in the extent of early (2 days after TACE) and delayed (35 to 40 days after TACE) necrosis were quantitatively and subjectively assessed. Early post-TACE tumor necrosis ranged from 21% to 70% (mean 43.5% +/- 19%). There was a statistically significant (p = 0.0012, paired Student t test) higher percentage of delayed tumor necrosis, which ranged from 24% to 88% (mean 52.3% +/- 20.3%). Subjective evaluation showed a delayed obvious increase of the necrotic areas in 5 patients. In 2 patients, tumor vessels that initially remained patent disappeared on the delayed follow-up. A part of tumor necrosis after chemoembolisation of HCC with DEB seems to take place later than 2 days after TACE. CEUS may provide evidence for the sustained antitumor effect of DEB-TACE. Nevertheless, the ideal time for the imaging evaluation of tumor response remains to be defined.
- Subjects :
- Male
medicine.medical_specialty
Necrosis
Carcinoma, Hepatocellular
Sulfur Hexafluoride
Pilot Projects
Tumor response
Sampling Studies
medicine
Humans
Radiology, Nuclear Medicine and imaging
Doxorubicin
Chemoembolization, Therapeutic
Phospholipids
Ultrasonography, Interventional
Aged
Neoplasm Staging
Drug eluting beads
business.industry
Ultrasound
Liver Neoplasms
Middle Aged
medicine.disease
Image Enhancement
Microspheres
Survival Rate
Treatment Outcome
Liver
Hepatocellular carcinoma
Tumor necrosis factor alpha
Female
Radiology
Ultrasonography
medicine.symptom
Cardiology and Cardiovascular Medicine
business
Nuclear medicine
Tomography, X-Ray Computed
medicine.drug
Follow-Up Studies
Subjects
Details
- ISSN :
- 1432086X
- Volume :
- 33
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- Cardiovascular and interventional radiology
- Accession number :
- edsair.doi.dedup.....15c6022f4e04746972b3a01ba450c891